Pages that link to "Item:Q1773294"
From MaRDI portal
The following pages link to The evaluation of surrogate endpoints. (Q1773294):
Displaying 9 items.
- Robust Approach to Combining Multiple Markers to Improve Surrogacy (Q6079767) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Assurance in vaccine efficacy clinical trial design based on immunological responses (Q6085899) (← links)
- One-step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure-time endpoints (Q6624663) (← links)
- Predictive probability of success using surrogate endpoints (Q6625585) (← links)
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q6628174) (← links)
- Using a surrogate with heterogeneous utility to test for a treatment effect (Q6629910) (← links)
- Flexible evaluation of surrogate markers with Bayesian model averaging (Q6630321) (← links)
- An information-theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: application to vaccine evaluation (Q6630352) (← links)
